We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
(-8.1%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-13.95%
Top 10 Holdings %
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$10.9M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$7.33M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$7.14M |
| 4 |
NetEase
NTES
|
+$7.01M |
| 5 |
Micron Technology
MU
|
+$6.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$65.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$62.2M |
| 3 |
Li Auto
LI
|
+$29.4M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$15.1M |
| 5 |
Alibaba
BABA
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Consumer Discretionary | 11.71% |
| 3 | Healthcare | 9.05% |
| 4 | Industrials | 8.79% |
| 5 | Financials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Baxter International
BAX
$14.2B
| $364K | 0.02% |
7,997
+2,537
| +46% | +$110K |
|
577
Avient
AVNT
$4.19B
| $363K | 0.02% |
8,886
+2,888
| +48% | +$113K |
|
578
Warby Parker
WRBY
$3.27B
| $363K | 0.02% |
+31,087
| New | +$354K |
|
579
American Express Global Business Travel
GBTG
$4.94B
| $362K | 0.02% |
50,013
+6,121
| +14% | +$41.7K |
|
580
Janus International
JBI
$757M
| $358K | 0.02% |
33,569
+11,813
| +54% | +$111K |
|
581
Truist Financial
TFC
$64B
| $356K | 0.02% |
11,741
+485
| +4% | +$15.1K |
|
582
PPG Industries
PPG
$26.6B
| $353K | 0.02% |
+2,382
| New | +$332K |
|
583
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $348K | 0.02% |
+18,000
| New | +$361K |
|
584
Mercury Systems
MRCY
$6.52B
| $346K | 0.02% |
+9,997
| New | +$427K |
|
585
Neuronetics
STIM
$166M
| $346K | 0.02% |
160,808
-20,255
| -11% | -$49.1K |
|
586
Asana
ASAN
$2.13B
| $343K | 0.02% |
15,568
-9,581
| -38% | -$192K |
|
587
Idexx Laboratories
IDXX
$46.2B
| $339K | 0.02% |
675
-66
| -9% | -$31.6K |
|
588
PUT
Silicon Motion
SIMO
$8.68B
| $338K | 0.02% |
+4,700
| New | +$300K |
|
589
Silicom
SILC
$242M
| $337K | 0.02% |
9,152
-5,144
| -36% | -$182K |
|
590
Sabesp
SBS
$18.7B
| $337K | 0.02% |
146,713
-1,068
| -0.7% | -$2.14K |
|
591
Herc Holdings
HRI
$5.61B
| $335K | 0.02% |
2,451
+577
| +31% | +$63.9K |
|
592
PUT
Simon Property Group
SPG
$72.3B
| $335K | 0.02% |
+2,900
| New | +$316K |
|
593
Pfizer
PFE
$153B
| $335K | 0.02% |
9,123
+1,837
| +25% | +$71.5K |
|
594
Apogee Enterprises
APOG
$908M
| $333K | 0.02% |
7,023
-6,036
| -46% | -$252K |
|
595
Legend Biotech
LEGN
$4.01B
| $333K | 0.02% |
4,822
-11,178
| -70% | -$730K |
|
596
IDEX
IEX
$17.3B
| $332K | 0.02% |
1,542
+87
| +6% | +$18.3K |
|
597
Hyatt Hotels
H
$16.7B
| $332K | 0.02% |
+2,896
| New | +$328K |
|
598
NXP Semiconductors
NXPI
$60.4B
| $330K | 0.02% |
1,610
+284
| +21% | +$50.5K |
|
599
Bioceres Crop Solutions
BIOX
$22M
| $329K | 0.02% |
24,631
-10,173
| -29% | -$119K |
|
600
BridgeBio Pharma
BBIO
$16.5B
| $328K | 0.02% |
19,041
+3,764
| +25% | +$56.6K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.
- Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
- Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
- Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
- Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
- Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
- Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.